A phase 1 dose-escalation study of GCC19CART: A novel CAR T-cell therapy for metastatic colorectal cancer in the United States. Obesity (BMI ≥ 30) 7.9% (406) 14.0% (714) 0.53 [0.47 - 0.60] Propensity ...
Racial disparities in major adverse cardiovascular and cerebrovascular events outcomes among hospitalized cholangiocarcinoma patients.
Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results